U.S. Pharmacist eNewsletter
July 2022

ACIP Prefers High-Dose Flu Vaccine for Older Recipients
This past flu season, public health officials expressed no preference on whether influenza vaccine recipients should receive the standard or enhanced vaccine. That is likely to be different next year because a CDC panel voted unanimously to prefer an enhanced quadrivalent inactivated vaccine for that age group. Read more.


Study: Post-RSV Vaccination Flares in Inflammatory Disease Patients
Despite some concerns raised in the past, patients with a range of immune-mediated inflammatory diseases did not have a greater risk of disease flares after receiving the recombinant zoster vaccine (RZV). Those patients are at an increased risk of herpes zoster, however. Learn more about vaccine uptake in those patients from a study published in Arthritis & Rheumatology.


Should Homeless People Routinely Get a Meningococcal Vaccine?
Several outbreaks of invasive meningococcal disease have occurred recently in people experiencing homelessness, and a new study found that the risk is generally higher in that cohort compared with those who have homes. Public health officials from the CDC are now calling for an analysis of routine vaccination for that group. Learn more about the results of their study.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
Advertisement Advertisement